Medication counseling can fail when information is linguistically inaccessible, exceeds patients’ literacy or information-processing capacity, conflicts with cultural or contextual expectations, or depends on digital resources that patients cannot readily use. Adaptations intended to address these barriers vary substantially in what they modify and in how their value is evaluated. To map strategies used from 2017 through 2024 to adapt medication counseling across language, literacy, cultural, and digital-access barriers and to distinguish the barriers targeted from the evaluation methods and outcomes used to judge those adaptations. A scoping review was conducted using PRISMA-ScR reporting principles. Searches combined concepts related to medication counseling and pharmaceutical care with language concordance, limited English proficiency, health and medication literacy, visual communication, cultural tailoring, telepharmacy, digital literacy, and evaluation outcomes. Records were screened without journal-quartile restrictions. Eighty-three records were identified, 14 duplicates were removed, and 69 records were screened. Thirty-eight reports underwent full-text assessment; 9 were excluded, leaving 29 evidence sources in the scoping synthesis. Evidence was charted separately for barrier context, adaptation strategy, delivery mode, population and setting, and evaluation endpoint. Adaptations included bilingual and language-concordant communication, pictograms and redesigned written instructions, teach-back and other comprehension-verification methods, culturally or population-responsive counseling, and digitally mediated or combined human–digital approaches. Evaluation was uneven. Comprehension, knowledge, preference, acceptability, and feasibility were assessed more frequently than demonstrated medication-use behavior, equitable access, quality of life, or clinical outcomes. Several studies also showed that favorable preference or acceptability did not necessarily correspond to improved task performance or downstream outcomes. Medication-counseling adaptations cannot be interpreted as a single intervention class. Their evidentiary meaning depends on what was adapted, which barrier or context was addressed, how counseling was delivered, and which outcome was measured. Separating these dimensions exposes important gaps between adaptation feasibility, patient experience, comprehension, behavior, equitable reach, and clinical benefit.
